Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alcon Inc (ALC)

Alcon Inc (ALC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,383,936
  • Shares Outstanding, K 493,100
  • Annual Sales, $ 9,455 M
  • Annual Income, $ 974,000 K
  • 60-Month Beta 0.97
  • Price/Sales 4.70
  • Price/Cash Flow 17.17
  • Price/Book 2.13
Trade ALC with:
  • Price/Earnings ttm 31.80
  • Earnings Per Share ttm 2.83
  • Most Recent Earnings $0.78 on 05/13/24
  • Next Earnings Date 08/20/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-3851 Ophthalmic Goods

    Medical Instruments

Options Overview Details

View History
  • Implied Volatility 21.97% ( +0.27%)
  • Historical Volatility 16.05%
  • IV Percentile 51%
  • IV Rank 34.94%
  • IV High 36.27% on 11/01/23
  • IV Low 14.30% on 03/15/24
  • Put/Call Vol Ratio 0.61
  • Today's Volume 167
  • Volume Avg (30-Day) 351
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 7,165
  • Open Int (30-Day) 8,533

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.74
  • Number of Estimates 5
  • High Estimate 0.77
  • Low Estimate 0.72
  • Prior Year 0.69
  • Growth Rate Est. (year over year) +7.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.79 +3.44%
on 07/10/24
92.58 -1.92%
on 07/12/24
+1.68 (+1.89%)
since 06/21/24
3-Month
77.54 +17.11%
on 04/30/24
92.65 -1.99%
on 06/12/24
+10.19 (+12.65%)
since 04/22/24
52-Week
69.44 +30.77%
on 10/26/23
92.65 -1.99%
on 06/12/24
+6.50 (+7.70%)
since 07/21/23

Most Recent Stories

More News
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.6800 (+1.20%)
ALC : 90.80 (+0.88%)
BLCO : 17.30 (+1.88%)
JNJ : 154.25 (-0.28%)
RHHBY : 39.3900 (+0.31%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

/PRNewswire/ -- The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome...

OKYO : 1.6800 (+1.20%)
ALC : 90.80 (+0.88%)
BLCO : 17.30 (+1.88%)
JNJ : 154.25 (-0.28%)
RHHBY : 39.3900 (+0.31%)
Stock Index Futures Plunge on Pressure from Rising Bond Yields, China Data Disappoints

September S&P 500 futures (ESU23) are down -0.61%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.48% this morning as market participants digested the latest U.K. employment data, which fueled...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
NVDA : 123.43 (+4.66%)
X : 38.10 (-0.21%)
MNDY : 235.64 (+3.06%)
TSLA : 251.61 (+5.19%)
KEY : 15.77 (+1.15%)
CMA : 51.11 (+1.37%)
HD : 363.25 (-0.03%)
SU : 38.78 (+0.67%)
ALC : 90.80 (+0.88%)
A : 133.42 (+1.24%)
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the American Society of Cataract and Refractive Surgery...

ALC : 90.80 (+0.88%)
Alcon Announces Results of 2023 Annual General Meeting

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2023 Annual General Meeting (AGM)....

ALC : 90.80 (+0.88%)
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy

The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...

MMED.NE : 14.9000 (+9.48%)
MNMD : 8.61 (+8.58%)
INCY : 65.19 (-1.03%)
SGEN : 228.74 (-0.07%)
PFE : 29.64 (-1.10%)
FBRX : 0.5950 (+0.85%)
JAZZ : 109.70 (+0.63%)
ALC : 90.80 (+0.88%)
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have the largest surgical ophthalmic presence at the American Society of Cataract and Refractive...

ALC : 90.80 (+0.88%)
Alcon Publishes Agenda for 2023 Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 5, 2023.

ALC : 90.80 (+0.88%)
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce...

ALC : 90.80 (+0.88%)
Alcon to Host 2023 Capital Markets Day

Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2023 Capital Markets Day on March 30, 2023 beginning at 8:00 a.m. CT.

ALC : 90.80 (+0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma...

See More

Key Turning Points

3rd Resistance Point 90.73
2nd Resistance Point 90.54
1st Resistance Point 90.27
Last Price 90.80
1st Support Level 89.81
2nd Support Level 89.62
3rd Support Level 89.35

See More

52-Week High 92.65
Last Price 90.80
Fibonacci 61.8% 83.78
Fibonacci 50% 81.04
Fibonacci 38.2% 78.31
52-Week Low 69.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar